<?xml version="1.0" encoding="UTF-8"?>
<ListBucketResult xmlns="http://s3.amazonaws.com/doc/2006-03-01/"><Name>biometric-references-gender</Name><Prefix></Prefix><Marker></Marker><MaxKeys>1000</MaxKeys><IsTruncated>false</IsTruncated><Contents><Key>20-07-08: Factors associated with COVID-19-related death using OpenSAFELY.pdf</Key><LastModified>2020-12-28T17:11:20.000Z</LastModified><ETag>&quot;e8f5da8def2f2210fc76277aa0209103&quot;</ETag><Size>5221935</Size><StorageClass>STANDARD</StorageClass></Contents><Contents><Key>20-09-08: In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age</Key><LastModified>2021-02-17T21:29:18.000Z</LastModified><ETag>&quot;2aa13ff992cb683c14f5ba84bd5e8a46&quot;</ETag><Size>2808726</Size><StorageClass>STANDARD</StorageClass></Contents><Contents><Key>2020-01: Percentage of adults in the U.S. who had coronary heart disease in 2013-2016, by age and gender</Key><LastModified>2020-11-08T21:15:23.000Z</LastModified><ETag>&quot;e5724268585ee76810d037ef9d66691d&quot;</ETag><Size>51495</Size><StorageClass>STANDARD</StorageClass></Contents><Contents><Key>2020-02-07: Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China</Key><LastModified>2020-10-20T19:00:17.000Z</LastModified><ETag>&quot;9c0af73c27ddb3e5ac07278a3146bfe4&quot;</ETag><Size>714968</Size><StorageClass>STANDARD</StorageClass></Contents><Contents><Key>2020-02-09: Clinical characteristics of 2019 novel coronavirus infection in China</Key><LastModified>2020-10-20T19:00:17.000Z</LastModified><ETag>&quot;41b068a9eaae2f7a735c5d6a3f1584a4&quot;</ETag><Size>916300</Size><StorageClass>STANDARD</StorageClass></Contents><Contents><Key>2020-02-15: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</Key><LastModified>2020-10-20T19:00:17.000Z</LastModified><ETag>&quot;e72dbbddde5cba73a8738a522c22a623&quot;</ETag><Size>1288110</Size><StorageClass>STANDARD</StorageClass></Contents><Contents><Key>2020-03-29: Gender Differences in Patients With COVID-19: Focus on Severity and Mortality</Key><LastModified>2020-10-20T19:00:17.000Z</LastModified><ETag>&quot;8a5c0e98d1588f6980af384219535ec4&quot;</ETag><Size>560607</Size><StorageClass>STANDARD</StorageClass></Contents><Contents><Key>2020-05-25: Impact of sex and gender on COVID-19 outcomes in Europe</Key><LastModified>2020-10-20T19:00:17.000Z</LastModified><ETag>&quot;81141f698353a4211486d0d77ad42593&quot;</ETag><Size>1885190</Size><StorageClass>STANDARD</StorageClass></Contents><Contents><Key>2020-06-19: Screening for low testosterone is needed for early identification and treatment of men at high risk of mortality from Covid-19</Key><LastModified>2020-10-20T19:00:17.000Z</LastModified><ETag>&quot;de05ba0048faf0d7c3b041236dae94c0&quot;</ETag><Size>206987</Size><StorageClass>STANDARD</StorageClass></Contents><Contents><Key>2020-07-15: Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic</Key><LastModified>2020-11-10T16:18:43.000Z</LastModified><ETag>&quot;9e510f6329c047ec43d5c4c78920f09f&quot;</ETag><Size>882349</Size><StorageClass>STANDARD</StorageClass></Contents><Contents><Key>2020-07-22: Male balding is a major risk factor for severe COVID-19</Key><LastModified>2020-10-27T20:36:03.000Z</LastModified><ETag>&quot;6bc38740fe5a7e62281914e8240b7940&quot;</ETag><Size>160250</Size><StorageClass>STANDARD</StorageClass></Contents><Contents><Key>2020-08-22: Sex and gender: modifiers of health, disease, and medicine</Key><LastModified>2020-10-27T00:02:01.000Z</LastModified><ETag>&quot;69e467228170b1000a07b79a5ba3d809&quot;</ETag><Size>838047</Size><StorageClass>STANDARD</StorageClass></Contents></ListBucketResult>